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Abstract
Aim: As a result of the difficulty in effective prevention of gastroesophageal reflux, 
no standard reconstruction procedure after proximal gastrectomy (PG) has yet been 
established. The double- flap technique (DFT), or Kamikawa procedure, is an antire-
flux reconstruction procedure in esophagogastrostomy. The efficacy of DFT has re-
cently been reported in several studies. However, these were all single- center studies 
with a limited number of cases.
Methods: We conducted a multicenter retrospective study in which patients who 
underwent DFT, irrespective of disease type and reconstruction approach, at each 
participating institution between 1996 and 2015 were registered. Primary endpoint 
was incidence of reflux esophagitis at 1- year after surgery, and secondary endpoint 
was incidence of anastomosis- related complications.
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1  | INTRODUC TION
No standard reconstruction procedure after proximal gastrectomy 
(PG) has yet been established.1 PG is mainly indicated for diseases 
located in the upper- third of the stomach, such as gastric cancer and 
submucosal tumor, and recently also for esophagogastric junction 
(EGJ) cancer. The biggest change caused by PG is loss of the cardia, 
which plays an extremely important role in antireflux mechanisms, 
preventing reflux of gastric contents into the esophagus. Although 
esophagogastrostomy (EG) has the benefits of simplicity and being 
more physiological, EG with no specific procedure is likely to cause 
severe reflux esophagitis after surgery, leading to substantial decline 
in the patient’s quality of life (QOL).2 Although other reconstruction 
procedures, such as jejunal interposition (JI),3 jejunal pouch interpo-
sition (JPI)4 and the double- tract (DT) method,5 in which some dis-
tance is maintained between the esophagus and gastric remnant, are 
alternative procedures and are efficient in preventing reflux to some 
extent, these procedures sometimes cause other problems that are 
unlikely with EG, such as obstruction of the passage and difficulty in 
endoscopic surveillance of the gastric remnant after surgery.6
The double- flap technique (DFT), also known as Kamikawa pro-
cedure, which was first reported in 1998, is an antireflux procedure 
during EG after PG. DFT consists of a unique multistep process in-
volving creation of an H- shaped seromuscular double- flap, fixing the 
esophagus and the gastric remnant, and anastomosis and closure of 
the double- flap, all of which are basically carried out by hand- sewn 
techniques.7 In this procedure, the distal esophagus and anastomo-
sis are embedded in the submucosal layer of the gastric remnant and 
covered by the seromuscular double- flap, which is designed to func-
tion as a one- way valve to prevent reflux. We previously reported 
the efficacy of DFT in the reconstruction of antireflux mechanisms, 
in addition to its ease of performance by laparoscopy through stan-
dardization of the procedure and proficiency in laparoscopic sutur-
ing and ligation techniques.7,8 The efficacy of this procedure has also 
been reported by other institutions,9,10 including reporting of the 
feasibility of intrathoracic DFT.11,12 However, these reports are all 
based on single institution studies with a limited number of cases, 
raising concerns about its universality.
In the present study, we aimed to evaluate the universal feasi-
bility of DFT in terms of its efficacy as an antireflux technique and 
its safety in terms of anastomosis- related complications by retro-
spectively collecting DFT cases from multiple institutions. The study 
population was not limited only to patients with gastric cancer, and 
other diseases, such as EGJ cancers and gastric submucosal tumor 
(SMT), were also included. Further, the reconstruction approach was 
not limited to either laparotomy or laparoscopy, but both approaches 
were accepted. We believe that this multicenter study with a large 
number of DFT cases will facilitate the recognition of DFT as a stan-
dard reconstruction procedure after PG.
2  | METHODS
2.1 | Surgical procedure of DFT
The detailed step- by- step procedure and technique of DFT has been 
described in detail in a previous report.7 Briefly, an H- shaped sero-
muscular flap (2.5 × 3.5 cm) is first created on the anterior wall of 
the gastric remnant. The posterior side of the esophagus is fixed by 
four- point sutures to the gastric remnant at the upper edge of the 
flap. Anastomosis of the posterior wall is carried out by a single- layer 
continuous suture between all layers of the esophagus and mucosa 
of the stomach, and anastomosis of the anterior wall is carried out 
Results: Of 546 patients who were eligible for this study, 464 patients who had en-
doscopic examination at 1- year follow up were evaluated for reflux esophagitis. 
Incidence of reflux esophagitis of all grades was 10.6% and that of grade B or higher 
was 6.0%. Male gender and anastomosis located in the mediastinum/intra- thorax 
were independent risk factors for grade B or higher reflux esophagitis (odds ratio 
[OR]: 4.21, 95% confidence interval [CI]: 1.44- 10.9, P = 0.0109). Total incidence of 
anastomosis- related complications was 7.2%, including leakage in 1.5%, strictures in 
5.5% and bleeding in 0.6% of cases. Laparoscopic reconstruction was the only inde-
pendent risk factor for anastomosis- related complications (OR: 3.93, 95% CI: 1.93- 
7.80, P = 0.0003).
Conclusion: Double- flap technique might be a feasible option after PG for effective 
prevention of reflux, although anastomotic stricture is a complication that must be 
well- prepared for.
K E Y W O R D S
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proximal gastrectomy
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by layer- to- layer suturing. The DFT reconstruction is completed 
by closing the double- flap in a Y- shape with interrupted sutures to 
cover the anastomosis.
2.2 | Study design
Eighteen institutions participated in the present study. Patients who 
underwent DFT after PG, irrespective of disease type and recon-
struction approach, at each participating institution between January 
1st 1996 and December 31st 2015 were retrospectively registered. 
This study conforms to the provisions of the Declaration of Helsinki, 
and the protocol was approved by the Okayama University Hospital 
Institutional Review Board (Approval no. 1705- 023) and the institu-
tional review boards of each participating institution.
2.3 | Medical records
Characteristics of patients before surgery, including age, gender, 
height, body weight, body mass index (BMI), prognostic nutritional 
index (PNI) and disease type, such as gastric cancer, EGJ cancer and 
gastric SMT, were recorded. In gastric cancer cases, information on 
histological type, pathological T status (pT), pathological N status 
(pN) and pathological M status (pM) was also described according 
to the 3rd English edition of the Japanese Classification of Gastric 
Carcinoma.13 Surgical factors included operation time, blood loss, ex-
tent of lymph node dissection, presence of nerve (celiac branch and 
hepatic branch) preservation, approach for reconstruction, such as 
laparotomy, thoraco- laparotomy, mini- laparotomy and laparoscopy, 
location of anastomosis (intra- abdominal or mediastinal/intratho-
racic), duration of hospital stay postoperatively and postoperative 
complications. The approach was considered to be a mini- laparotomy 
when reconstruction was carried out through an 8- cm or shorter skin 
incision, and it was considered a laparoscopic procedure only when 
all reconstruction processes were carried out under laparoscopy. At 
1- year follow up, information on reflux esophagitis according to en-
doscopic examination, as well as body weight, PNI, and regular use of 
an H2 blocker or proton- pump inhibitor (PPI) was registered.
2.4 | Endpoints
Primary endpoint of this study was the incidence of reflux esophagi-
tis approximately 1 year after surgery, which was evaluated using 
endoscopic examination and scored according to the Los Angeles 
classification (Grade A to D).14 Secondary endpoint was the incidence 
of anastomosis- related complications, such as leakage, stricture and 
bleeding, which were assessed according to the Clavien- Dindo (CD) 
classification.15 Stricture was considered relevant only when its CD 
grade was IIIa (requiring balloon dilatation, stenting, or magnetic 
compression anastomosis) or higher.
2.5 | Statistical analysis
Statistical analysis was conducted using JMP software ver.10.0.2 
(SAS Institute, Cary, NC, USA). Univariate and multivariate logistic 
regression analyses were carried out to assess the risk factors for 
reflux esophagitis and anastomosis- related complications. P val-
ues < 0.05 were considered statistically significant.
3  | RESULTS
A total of 546 patients were finally enrolled in the present study 
from among the 549 cases originally identified after three cases 
were excluded because of failure to meet inclusion criteria (Figure 1). 
The primary endpoint was assessed in 464 patients who under-
went endoscopic examination approximately 1 year after surgery, 
whereas the secondary endpoint and other analyses were assessed 
in the 546 patients.
F IGURE  1 CONSORT diagram for the 
present study
     |  99KURODA et Al.
Gastric cancer was the most common (86.6%) disease registered 
in this study, followed by EGJ cancer (6.6%), gastric SMT (5.7%) and 
others (1.1%) (Table 1). Of the 473 gastric cancer cases, differenti-
ated type, pT1, pN0 and pM0 accounted for 74.6%, 78.0%, 89.1% 
and 98.5% of the cases, respectively (Table S1). In terms of surgical 
factors, the reconstruction procedure was carried out by laparotomy 
in 57.0%, thoraco- laparotomy in 4.6%, mini- laparotomy in 23.1% and 
by laparoscopy in 14.8%, and the anastomotic site was located in the 
abdominal cavity in 92.1% and in the mediastinum/intra- thorax in 
7.9% (Table 2). Celiac and hepatic branches of the vagus nerve were 
preserved in 46.3% and 70.1% of patients, respectively.
Endoscopic examination carried out at 1.0 year (median) after 
surgery showed that the incidence of reflux esophagitis, the primary 
endpoint, was 10.6% for all grades, with an incidence of 4.5% for 
grade A reflux, 4.3% for grade B, 1.3% for grade C and 0.4% for grade 
D reflux (Figure 2). The incidence of grade B or higher reflux esoph-
agitis was 6.0%. In gastric cancer cases alone, the incidence of reflux 
esophagitis was 9.6% for all grades and 4.9% for grade B or higher 
(Figure S1). Univariate and multivariate analysis showed that anas-
tomosis located in the mediastinum/intra- thorax was an indepen-
dent risk factor for grade B or higher reflux esophagitis (odds ratio 
[OR]: 4.21, 95% confidence interval [CI]: 1.44- 10.9, P = 0.0109), as 
was male gender (OR: 4.64, 95% CI: 1.35- 29.2, P = 0.0117) (Table 3). 
When limited to cases in which anastomosis was located in the medi-
astinum/intra- thorax, the incidence of reflux esophagitis was as high 
as 24.3% for all grades and 18.2% for grade B or higher. However, 
when these cases were historically divided into two groups, the inci-
dence of reflux esophagitis in the late period (2014- 2015) was 11.7% 
for all grades and 5.9% for grade B or higher, which was substan-
tially reduced compared to 37.5% for all grades and 31.2% for grade 
B or higher in the early period (1996- 2013). The percentage of pa-
tients who regularly took H2 blockers or PPI at 1 year after surgery 
was 24.7%, and this percentage was significantly higher (47.5%) in 
patients who suffered from reflux esophagitis at 1 year after sur-
gery (P = 0.0004). Percentage change in body weight at 1 year after 
surgery in comparison with before surgery was −11.3%, whereas 
the change in PNI was only −1.8% (Figure S2). There was no correla-
tion between the severity of weight loss and the incidence of reflux 
esophagitis (P = 0.6776).
The incidence of anastomosis- related complications, the second-
ary endpoint, was 7.2% (Figure 3). Strictures were the most frequent 
complication observed in 5.5% of patients, whereas leakage and 
bleeding were observed in as few as 1.5% and 0.6% of patients, re-
spectively. All three patients who suffered from anastomotic bleeding 
had severe blood loss during surgery, whereas no specific finding was 
observed in eight patients who suffered from anastomotic leakage 
(Table S2). In gastric cancer cases alone, strictures were observed 
in 6.0% of patients (Figure S1). Univariate and multivariate analysis 
showed that laparoscopic reconstruction was the only significant 
risk factor for anastomosis- related complications (OR: 3.93, 95% CI: 
1.93- 7.80, P = 0.0003) (Table 4). Similarly, when anastomotic stricture 
was the only complication assessed, laparoscopic reconstruction was 
the only significant risk factor for development of this complication 
(OR: 5.53, 95% CI: 2.55- 11.8, P < 0.0001) (Table S3). In an assessment 
of 81 cases of laparoscopic reconstruction, when the incidence of 
anastomosis- related complications was assessed focusing on DFT ex-
perience at each institution, the incidence was shown to reduce by ap-
proximately 50% after the experience of 11 or more cases (Figure S3).
TABLE  1 Characteristics of patients in the present study
Age
Mean ± SD 68.2 ± 11.1
Gender
Male 407 (74.5%)
Female 139 (25.5%)
BMI, kg/m2
Mean ± SD 23.0 ± 3.3
PNI
Mean ± SD 50.6 ± 6.0
Disease
Gastric cancer 473 (86.6%)
EGJ cancer 36 (6.6%)
Gastric SMT 31 (5.7%)
Others 6 (1.1%)
BMI, body mass index; EGJ, esophagogastric junction; PNI, prognostic 
nutritional index; SD, standard deviation; SMT, submucosal tumor.
TABLE  2 Surgical factors of patients in the present study
Operation time, min
Median (IQR) 298 (247.5- 370.5)
Blood loss, mL
Median (IQR) 240 (100- 392.5)
Lymph node dissection
D0 43 (7.9%)
D1/1+ 487 (89.2%)
Others 16 (2.9%)
Nerve preservation
Celiac branch 253 (46.3%)
Hepatic branch 383 (70.1%)
Approach for reconstruction
Laparotomy 311 (57.0%)
Thoraco- laparotomy 25 (4.6%)
Mini- laparotomy 126 (23.1%)
Laparoscopy 81 (14.8%)
Others 3 (0.5%)
Location of anastomosis
Intra- abdomen 503 (92.1%)
Mediastinum/Intra- thorax 43 (7.9%)
Postoperative length of hospital stay, days
Median (IQR) 15 (13- 20)
IQR, interquartile range.
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4  | DISCUSSION
In the evaluation of reconstruction procedures after PG, the inci-
dence of reflux esophagitis, which is a unique aspect of PG and a 
major reason why establishment of a standard reconstruction pro-
cedure after PG is difficult, is a critical factor determining patients’ 
long- term QOL after surgery. Patients who have reflux esophagitis 
after surgery sometimes suffer from severe symptoms, such as re-
gurgitation, heartburn and cough, for an extended period of time. 
Simple EG without any additional antireflux procedure has been re-
ported to cause reflux esophagitis in 9.1%- 35.3% of patients, and 
even JI, JPI and DT, which are supposed to prevent the occurrence of 
reflux, resulted in reflux esophagitis in 0%- 15.8%, 8.3%- 15.8% and 
0%- 25% of cases, respectively, which are not negligible incidences.2 
Some EG with additional antireflux procedures, such as fundopli-
cation, successfully reduced the incidence of reflux esophagitis to 
below 10%,16,17 whereas other EG failed to prevent the occurrence 
of reflux even with additional antireflux procedures, resulting in re-
flux esophagitis in over 30% of cases.18,19 Previous DFT reports that 
included a variety of cases (n = 112) showed that DFT successfully 
prevented the occurrence of reflux esophagitis (≥grade B) with an 
incidence of 2.7% (3/112).7–10 In the present study, the incidence of 
reflux esophagitis was 10.6% for all grades and 6.0% for grade B or 
higher esophagitis in the analysis of as many as 464 patients, which 
is considered closer to “real- world data”. One of the independent 
risk factors for reflux esophagitis (grade B or higher) was the anas-
tomotic site in the mediastinum/intra- thorax, which is considered 
reasonable as a result of the negative pressure of the intrathoracic 
F IGURE  2  Incidence of reflux esophagitis in the present study
Univariate Multivariate
P value OR 95% CI P value
Age (≥80 y) 0.4513
Gender (Male) 0.0120 4.64 1.35- 29.2 0.0117
BMI (≥25 kg/m2) 0.2216
PNI (<45) 0.1192
Disease (Cancer) 0.8459
Operation time (≥360 min) 0.6453
Blood loss (≥500 mL) 0.8482
Approach to reconstruction 
(Laparoscopy)
0.3608
Anastomotic location 
(Mediastinum/Intra- thorax)
0.0112 4.21 1.44- 10.9 0.0109
Experience (≤5 cases) 0.8726
Factors that showed a significant difference in univariate analysis were subjected to multivariate 
analysis.
BMI, body mass index; CI, confidence interval; OR, odds ratio; PNI, prognostic nutritional index.
TABLE  3 Risk factors for reflux 
esophagitis
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cavity. Another risk factor was male gender, and this may be related 
to the fact that gastroesophageal reflux disease, including reflux es-
ophagitis, is more often observed in males than in females.20 The 
biggest advantage of DFT is the effective prevention of reflux symp-
toms after surgery without the need for additional medications, such 
as H2 blockers or PPI, which is beneficial for patients and involves 
reduced treatment costs, although the need for a relatively long time 
for reconstruction may be a disadvantage. DFT carried out by hand- 
sewn techniques only is also associated with cost benefits compared 
to other reconstruction procedures using stapling devices.
With respect to anastomosis- related complications, stricture is 
considered the most frequent complication following DFT that re-
quires careful follow up, whereas leakage is unlikely to occur as a 
result of the nature of the reconstruction procedure, which involves 
placement of the anastomosis in the submucosal space by covering it 
with the seromuscular double- flap. Previous reports mentioned that 
anastomotic strictures requiring endoscopic balloon dilatation (CD 
grade IIIa) occurred in 13.4% (15/112) of patients, whereas anasto-
motic leakage occurred in only 0.9% (1/112).7–10 In the present study, 
we showed incidences of anastomotic stricture and anastomotic 
leakage of 5.5% and 1.5%, respectively, and the only risk factor for 
anastomosis- related complications was laparoscopic surgery. DFT 
was carried out by the laparoscopic (or robotic) approach in over 
80% of cases in previous reports, but in only 18.4% of cases in the 
present study, which may be the reason for the difference in the 
incidence of anastomotic strictures. Actually, the incidence of anas-
tomotic strictures in the present study was as high as 16.7% (14/84) 
when the cases with laparoscopic reconstruction were analyzed 
separately, which is similar to that previously reported. Laparoscopic 
procedures cannot be avoided both now and in the future as a recon-
struction approach after PG for early gastric cancer. As the present 
study showed, the learning curve was recognized as a factor associ-
ated with the incidence of anastomosis- related complications after 
laparoscopic DFT, as successful laparoscopic DFT involves certain 
F IGURE  3  Incidence of anastomosis- 
related complications in the present study
Univariate Multivariate
P value OR 95% CI P value
Age (≥80 y) 0.3129
Gender (Male) 0.2579
BMI (≥25 kg/m2) 0.8444
PNI (<45) 0.3621
Disease (Cancer) 0.6498
Operation time (≥360 min) 0.6377
Blood loss (≥500 mL) 0.4234
Approach to reconstruction 
(Laparoscopy)
0.0003 3.93 1.93- 7.80 0.0003
Anastomotic location 
(Mediastinum/Intra- thorax)
0.1410
Experience (≤5 cases) 0.5233
Factors that showed a significant difference in univariate analysis were subjected to multivariate 
analysis.
BMI, body mass index; CI, confidence interval; OR, odds ratio; PNI, prognostic nutritional index.
TABLE  4 Risk factors for anastomosis- 
related complications
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unique techniques. For this reason, laparoscopic DFT should be car-
ried out by or under the supervision of an experienced surgeon and 
unprepared introduction of DFT at inexperienced institutions should 
be avoided.
Although the present study has provided some important informa-
tion for clinical practice, it has several limitations. First, this was a ret-
rospective study and may have suffered from selection bias. Second, 
the study spanned a period of 20 years, which is a very long time for a 
clinical study and may have led to a decline in study quality. Third, eval-
uation of reflux esophagitis on endoscopic examination was carried 
out by investigator review, and not by central review, which is advo-
cated worldwide as a means of independent verification of clinical trial 
endpoints.21 Fourth, this study included multiple types of diseases, not 
only gastric cancer, but also EGJ cancer and SMT, requiring variable 
extents of lymph node dissection. This difference in extent of lymph 
node dissection is likely to influence the condition of the anastomotic 
site, including its blood supply, which has the potential to affect the 
incidence of both anastomosis- related complications and reflux esoph-
agitis. From this standpoint, studies targeting a single type of disease 
requiring the same extent of lymph node dissection may be preferable.
In conclusion, in the present multicenter retrospective study in-
volving a large cohort, the incidence of reflux esophagitis (grade B or 
higher) with DFT reconstruction after PG was 6.0%. In our opinion, 
this makes DFT more acceptable as a reconstruction procedure after 
PG as compared to other procedures. We also showed that the total 
incidence of anastomosis- related complications was 7.2%, including 
anastomotic strictures in 5.5% of cases, which reconfirmed the fact 
that patients who undergo PG with reconstructive procedures should 
be carefully followed up for postoperative anastomotic stricture for-
mation, as has also been previously reported. This study is thought to 
be valuable in providing more universal outcomes than previous re-
ports from single centers involving a limited number of cases. A mul-
ticenter prospective study will be required as the next step toward 
making DFT a standard reconstruction procedure after PG.
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